DR. MICHAEL MARTE M.D. NPI 1518058502

NPI Information

  • NPI: 1518058502
  • Provider Name: DR. MICHAEL MARTE, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2421 SILVER STREAM LN
    WILMINGTON, NC
    ZIP 28401
  • Phone: (910) 341-3300

Map and Directions

Get Directions

NPI Details

DR. Michael Marte, M.D. is a hematology and oncology internal medicine in Wilmington, NC with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Michael Marte, M.D. NPI is 1518058502. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Graduation Year:2003

The provider's business location address is:

2421 SILVER STREAM LN
WILMINGTON, NC
ZIP 28401-684
Phone: (910) 341-3300

The NPI 1518058502 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Magnesium level (HCPCS:83735)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Folic acid level, serum (HCPCS:82746)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Hepatitis b core antibody (igm) measurement (HCPCS:86705)
  • Hepatitis b surface antibody measurement (HCPCS:86706)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Blood creatinine level (HCPCS:82565)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Uric acid level, blood (HCPCS:84550)
  • Phosphate level (HCPCS:84100)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Automated urinalysis test (HCPCS:81003)

The enumeration date for this NPI number is 9/27/2006 and was last updated on 7/15/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology201701689NORTH CAROLINAYes
2207RH0003XInternal MedicineHematology & Oncology0101238722VIRGINIANo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.